| Financial Year |
March 31 2023 |
| Monetary Funds |
92,465,697.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
167,743,621.15 |
| Advances to Suppliers |
8,404,352.30 |
| Other Receivables |
335,060.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
71,566,575.13 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
23,924,453.03 |
| Total Current Assets |
371,224,384.45 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
16,189,890.43 |
| Fixed Assetes |
291,046,436.39 |
| Under-construction Projects |
254,434,765.10 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
129,063,094.98 |
| R&D expenses |
42,251,272.28 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
17,692,583.09 |
| Other Non-Current Assets |
21,149,853.35 |
| Sub-Total of Non-Current Assets |
962,527,956.63 |
| Total Assets |
1,333,752,341.08 |
| Short-Term Loans |
154,127,222.20 |
| Trading Financial liabilities |
-- |
| Notes Payable |
48,328,931.66 |
| Accounts Payable |
15,928,557.22 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
324,509.51 |
| Taxes Payable |
29,545,053.69 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
38,668,618.90 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
38,944,708.40 |
| Other Current Liabilities |
9,064,200.56 |
| Sub-Total of Current Liabilities |
337,832,055.86 |
| Long-term Loans |
8,100,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,036,430.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
33,075,936.08 |
| Total Liabilities |
370,907,991.94 |
| Paid-In Capital(Or Share Stock) |
120,000,000.00 |
| Capital Surplus |
210,285,601.01 |
| Surplus Reserve |
60,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
572,387,409.31 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
962,844,349.14 |
| Owner's Equity（Stockholder's Equity） |
962,844,349.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,333,752,341.08 |
